P4055

Description

Use SilverHawk's™ directional cutter to shave soft-to-mild plaque, while the nosecone captures the material for removal from the artery. The SilverHawk™ technology is backed by the landmark DEFINITIVE LE clinical study, which found that PAD patients with critical limb ischemia who were treated with plaque excision experienced a high rate (95%) of limb salvage at 12 months.¹

The SilverHawk™ peripheral plaque excision system is intended for use in atherectomy of the peripheral vasculature. The catheter is not intended for use in the coronary, carotid, iliac, or renal vasculature.

McKinsey JF, Zeller T, Rocha-Singh KJ, Jaff MR, Garcia LA, DEFINITIVE LE Investigators. Lower extremity revascularization using directional atherectomy: 12-month prospective results of the DEFINITIVE LE study. JACC Cardiovasc Interv. 2014;7(8):923–33.

Not what you're looking for?

Find more information, including other available configurations, for SilverHawk™ peripheral plaque excision system.

First Name

Last Name

Hospital Or Organization

Job Role

Specialty

Confirm country/region

Just to confirm, is this the product or product type that interests you?

{{productNamePlaceholder}}

Confirm country/region

Before we get started, what best describes you?

Confirm country/region

Before we get started, what best describes you?

First Name

Last Name

Hospital Or Organization

HOSPITAL POSTAL CODE

Job Role

Specialty

First Name

Last Name

PHONE

Hospital Or Organization

HOSPITAL POSTAL CODE

Job Role

Specialty

Description

Not what you're looking for?

United States

Customer Care Team